APA (7th ed.) Citation

Su, G., Yao, L., Han, X., Liao, X., Chen, J., Yin, T., . . . Mei, H. (2022). A synthetic targeted RNA demethylation system based on CRISPR‐Cas13b inhibits bladder cancer progression. Clinical & Translational Medicine, 12(2), 1. https://doi.org/10.1002/ctm2.734

Chicago Style (17th ed.) Citation

Su, Ganglin, et al. "A Synthetic Targeted RNA Demethylation System Based on CRISPR‐Cas13b Inhibits Bladder Cancer Progression." Clinical & Translational Medicine 12, no. 2 (2022): 1. https://doi.org/10.1002/ctm2.734.

MLA (9th ed.) Citation

Su, Ganglin, et al. "A Synthetic Targeted RNA Demethylation System Based on CRISPR‐Cas13b Inhibits Bladder Cancer Progression." Clinical & Translational Medicine, vol. 12, no. 2, 2022, p. 1, https://doi.org/10.1002/ctm2.734.